The correlation research of quantitative index of HRCT and lung function in patients with chronic obstructive pulmonary disease

doi:10.11958/20221162

Abstract

CLC Number:

R445.3

Figures/Tables 5

References 26

[1]	BURNEY P G, PATEL J, NEWSON R, et al. Global and regional trends in COPD mortality,1990-2010[J]. Eur Respir J, 2015, 45(5):1239-1247. doi:10.1183/09031936.00142414.
[2]	WANG C, XU J, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH]study):A national cross-sectional study[J]. Lancet, 2018, 391(10131):1706-1717. doi:10.1016/S0140-6736(18)30841-9.
[3]	王雯婷, 王晓华, 贺蓓, 等. 基于吸呼双相CT定量参数的慢性阻塞性肺疾病影像学表型研究[J]. 中华医学杂志, 2021, 101(28):2242-2245.
	WANG W T, WANG X X, HE B, et al. Imaging phenotypes of chronic obstructive pulmonary disease based on biphasic quantitative CT features[J]. Natl Med J China, 2021, 101(28):2242-2245. doi:10.3760/cma.j.cn112137-20201223-03443.
[4]	OSTRIDGE K, WILLIAMS N P, KIM V, et al. Relationship of CT-quantified emphysema,small airways disease and bronchial wall dimensions with physiological,inflammatory and infective measures in COPD[J]. Respir Res, 2018, 19(1):31. doi:10.1186/s12931-018-0734-y.
[5]	郭佑民, 金晨望, 曹宪宪. 定量CT在慢性阻塞性肺疾病诊疗中的应用[J]. 中国医学影像技术, 2020, 36(3):332-334.
	GUO Y M, JIN C W, CAO X X. Application of quantitative CT in diagnosis and treatment of chronic obstructive pulmonary disease[J]. Chinese Journal of Medical Imaging Technology, 2020, 36(3):332-334. doi:10.13929/j.issn.1003-3289.2020.03.002.
[6]	HOGG J C, PARÉ P D, HACKETT T L. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease[J]. Physiol Rev, 2017, 97(2):529-552. doi:10.1152/physrev.00025.2015.
[7]	曹宪宪, 金晨望, 郭佑民. CT定量评估肺气肿的研究现状[J]. 临床放射学杂志, 2019, 38(9):1787-1790.
	CAO X X, JIN C W, GUO Y M. Research status of CT quantitative evaluation of emphysema[J]. Journal of Clinical Radiology, 2019, 38(9):1787-1790. doi:10.13437/j.cnki.jcr.2019.09.047.
[8]	KONIETZKE P, WIELPÜTZ M O, WAGNER W L, et al. Quantitative CT detects progression in COPD patients with severe emphysema in a 3-month interval[J]. Eur Radiol, 2020, 30(5):2502-2512. doi:10.1007/s00330-019-06577-y.
[9]	王强, 罗勇, 李君. 慢性阻塞性肺疾病患者胸部高分辨率计算机断层成像肺气肿定量指标、气道管壁定量指标与肺功能的相关性研究[J]. 上海医学, 2020, 43(12):734-739.
	WANG Q, LUO Y, LI J. Correlation between chest high-resolution computed tomography quantitative indicators of emphysema, measurements of airway wall and pulmonary function test results in patients with chronic obstructive pulmonary disease[J]. Shanghai Med J, 2020, 43(12):734-739. doi:10.19842/j.cnki.issn.0253-9934.2020.12.006.
[10]	PARK J, HOBBS B D, CRAPO J D, et al. Subtyping COPD by using visual and quantitative CT imaging features[J]. Chest, 2020, 157(1):47-60. doi:10.1016/j.chest.2019.06.015.
[11]	马姣, 石芳, 崔涛, 等. 慢性阻塞性肺疾病患者高分辨率CT下表型的临床特征分析[J]. 国际呼吸杂志, 2019, 39(2):86-90.
	MA J, SHI F, CUI T, et al. Clinical characteristics and prognosis of chronic obstructive pulmonary disease phenotype classified by high resolution computer tomography[J]. International Journal of Respiration, 2019, 39(2):86-90. doi:10.3760/cma.j.issn.1673-436X.2019.02.002.
[12]	ZHANG L, JIANG B, WISSELINK H J, et al. COPD identification and grading based on deep learning of lung parenchyma and bronchial wall in chest CT images[J]. Br J Radiol, 2022, 95(1133):20210637. doi:10.1259/bjr.20210637.
[13]	LYNCH D A, AUSTIN J H, HOGG J C, et al. CT-definable subtypes of chronic obstructive pulmonary disease:A statement of the fleischner society[J]. Radiology, 2015, 277(1):192-205. doi:10.1148/radiol.2015141579.
[14]	LYNCH D A, MOORE C M, WILSON C, et al. CT-based visual classification of emphysema:Association with mortality in the COPDGene study[J]. Radiology, 2018, 288(3):859-866. doi:10.1148/radiol.2018172294.
[15]	SCHROEDER J D, MCKENZIE A S, ZACH J A, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema,air trapping,and airways in subjects with and without chronic obstructive pulmonary disease[J]. AJR Am J Roentgenol, 2013, 201(3):W460-W470. doi:10.2214/AJR.12.10102.
[16]	HAN M K, BARTHOLMAI B, LIU L X, et al. Clinical significance of radiologic characterizations in COPD[J]. COPD, 2009, 6(6):459-467. doi:10.3109/15412550903341513.
[17]	师美娟, 沈聪, 于楠, 等. 基于CT定量探讨不同级别慢性阻塞性肺疾病患者肺气肿肺叶分布[J]. 西安交通大学学报(医学版), 2019, 40(2):182-186.
	SHI M J, SHEN C, YU N, et al. Emphysema lobar distribution in patients with different degrees of chronic obstructive pulmonary disease based on quantitative CT analysis[J]. Journal of Xi'an Jiaotong University(Medical Sciences), 2019, 40(2):182-186. doi:10.7652/jdyxb201902003.
[18]	WRIGHT J L, LEVY R D, CHURG A. Pulmonary hypertension in chronic obstructive pulmonary disease:Current theories of pathogenesis and their implications for treatment[J]. Thorax, 2005, 60(7):605-609. doi:10.1136/thx.2005.042994.
[19]	黄晓旗, 牛媛, 雷禹, 等. 基于CT双气相定量研究吸烟合并慢性阻塞性肺疾病患者的肺叶小气道病变及肺气肿损伤程度[J]. 中华放射学杂志, 2022, 56(5):536-541.
	HUANG X Q, NIU Y, LEI Y, et al. Quantitative study on the degree of small airway disease and emphysema injury in pulmonary lobes of patients with smoking combined with chronic obstructive pulmonary disease based on biphasic CT[J]. Chin J Radiol, 2022, 56(5):536-541. doi:10.3760/cma.j.cn112149-20210428-00418.
[20]	XU F, VASILESCU D M, KINOSE D, et al. The molecular and cellular mechanisms associated with the destruction of terminal bronchioles in COPD[J]. Eur Respir J, 2022, 59(5):2101411. doi:10.1183/13993003.01411-2021.
[21]	TAKAYANAGI S, KAWATA N, TADA Y, et al. Longitudinal changes in structural abnormalities using MDCT in COPD:Do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression?[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12:551-560. doi:10.2147/COPD.S121405.
[22]	VASILESCU D M, MARTINEZ F J, MARCHETTI N, et al. Noninvasive imaging biomarker identifies small airway damage in severe chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2019, 200(5):575-581. doi:10.1164/rccm.201811-2083OC.
[23]	POMPE E, MOORE C M, MOHAMED HOESEIN F, et al. Progression of emphysema and small airways disease in cigarette smokers[J]. Chronic Obstr Pulm Dis, 2021, 8(2):198-212. doi:10.15326/jcopdf.2020.0140.
[24]	HOGG J C, CHU F, UTOKAPARCH S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease[J]. N Engl J Med, 2004, 350(26):2645-2653. doi:10.1056/NEJMoa032158.
[25]	QIN S, YU X, MA Q, et al. Quantitative CT analysis of small airway remodeling in patients with chronic obstructive pulmonary disease by a new image post-processing system[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16:535-544. doi:10.2147/COPD.S295320.
[26]	ZHAO D, ZHOU Y, JIANG C, et al. Small airway disease:A different phenotype of early stage COPD associated with biomass smoke exposure[J]. Respirology, 2018, 23(2):198-205. doi:10.1111/resp.13176.

组别	n		EI（%）
组别	n		左肺上叶		左肺下叶		右肺上叶		右肺中叶		右肺下叶
正常组	33		19.80（15.35，26.40）		15.40（10.15，22.55）		16.60（12.80，25.45）		23.80（14.70，28.70）		14.90（13.45，23.95）
COPD组	109		32.70（25.15，37.60）^a		29.40（20.55，36.55）^a		30.40（23.55，36.70）^a		31.30（24.90，39.35）^a		27.20（19.30，36.00）^a
GOLDⅠ级组	29		26.60（25.05，33.30）^a		20.60（16.55，29.40）		27.00（25.00，31.10）^a		27.00（22.60，33.40）		23.50（15.75，27.70）
GOLDⅡ级组	38		31.40（22.85，37.55）^a		28.45（20.10，35.53）^a		29.70（21.48，34.58）^a		30.90（25.90，38.23）^a		26.20（21.88，35.95）^a
GOLDⅢ+Ⅳ级组	42		35.80（26.4，41.83）^a		34.60（21.87，45.70）^abc		33.05（23.50，41.57）^a		37.75（26.60，44.08）^ab		35.55（25.58，42.98）^abc
χ²			5.128^＊＊		5.403^＊＊		5.142^＊＊		4.429^＊＊		5.144^＊＊
组别		MLD（HU）
组别		左肺上叶		左肺下叶		右肺上叶		右肺中叶		右肺下叶
正常组		-860（-873，-846）		-840（-856，-814）		-855（-869，-840）		-867（-867，-844）		-840（-856，-815）
COPD组		-875（-890，-860）^a		-865（-884，-842）^a		-870（-885，-855）^a		-878（-889，-861）^a		-860（-880，-835）^a
GOLDⅠ级组		-866（-885，-854）		-846（-871，-802）		-861（-879，-838）		-872（-884，-847）		-846（-865，-798）
GOLDⅡ级组		-873（-888，-862）^a		-861（-881，-840）^a		-870（-883，-856）^a		-875（-889，-859）		-852（-882，-820）
GOLDⅢ+Ⅳ级组		-884（-896，-867）^ab		-879（-898，-859）^ab		-874（-897，-861）^ab		-885（-896，-867）^ab		-877（-897，-859）^abc
χ²		3.585^＊＊		4.290^＊＊		3.495^＊＊		3.039^＊＊		3.340^＊＊

组别	n		EI（%）
组别	n		左肺上叶		左肺下叶		右肺上叶		右肺中叶		右肺下叶
正常组	33		19.80（15.35，26.40）		15.40（10.15，22.55）		16.60（12.80，25.45）		23.80（14.70，28.70）		14.90（13.45，23.95）
COPD组	109		32.70（25.15，37.60）^a		29.40（20.55，36.55）^a		30.40（23.55，36.70）^a		31.30（24.90，39.35）^a		27.20（19.30，36.00）^a
GOLDⅠ级组	29		26.60（25.05，33.30）^a		20.60（16.55，29.40）		27.00（25.00，31.10）^a		27.00（22.60，33.40）		23.50（15.75，27.70）
GOLDⅡ级组	38		31.40（22.85，37.55）^a		28.45（20.10，35.53）^a		29.70（21.48，34.58）^a		30.90（25.90，38.23）^a		26.20（21.88，35.95）^a
GOLDⅢ+Ⅳ级组	42		35.80（26.4，41.83）^a		34.60（21.87，45.70）^abc		33.05（23.50，41.57）^a		37.75（26.60，44.08）^ab		35.55（25.58，42.98）^abc
χ²			5.128^＊＊		5.403^＊＊		5.142^＊＊		4.429^＊＊		5.144^＊＊
组别		MLD（HU）
组别		左肺上叶		左肺下叶		右肺上叶		右肺中叶		右肺下叶
正常组		-860（-873，-846）		-840（-856，-814）		-855（-869，-840）		-867（-867，-844）		-840（-856，-815）
COPD组		-875（-890，-860）^a		-865（-884，-842）^a		-870（-885，-855）^a		-878（-889，-861）^a		-860（-880，-835）^a
GOLDⅠ级组		-866（-885，-854）		-846（-871，-802）		-861（-879，-838）		-872（-884，-847）		-846（-865，-798）
GOLDⅡ级组		-873（-888，-862）^a		-861（-881，-840）^a		-870（-883，-856）^a		-875（-889，-859）		-852（-882，-820）
GOLDⅢ+Ⅳ级组		-884（-896，-867）^ab		-879（-898，-859）^ab		-874（-897，-861）^ab		-885（-896，-867）^ab		-877（-897，-859）^abc
χ²		3.585^＊＊		4.290^＊＊		3.495^＊＊		3.039^＊＊		3.340^＊＊

组别		n	WA（mm²）			LA（mm²）			WA%
组别		n	4级	5级	6级	4级	5级	6级	4级	5级	6级
正常组	33		26.04±4.36	19.17±3.07	15.50±3.38	12.03±4.03	7.53±2.35	4.26±1.61	68.79±4.91	72.35±4.96	78.58±5.86
COPD组	109		26.84±4.60	20.26±3.09^a	16.47±3.45^a	11.43±2.74	6.50±1.61^a	3.57±1.07^a	70.27±4.15^a	75.87±3.65^a	82.45±3.67^a
GOLDⅠ级组	29		26.96±3.91	20.10±2.73^a	16.03±2.39	11.48±2.18	6.52±1.62^a	3.81±1.25^a	70.19±3.65^a	75.73±4.11^a	81.31±3.86^a
GOLDⅡ级组	38		27.15±5.23^a	20.37±3.28^a	16.76±4.52^ab	11.36±3.28	6.46±1.62^a	3.47±1.12^ab	70.44±5.30^a	76.49±3.40^a	83.10±3.98^ab
GOLDⅢ＋Ⅳ级组	42		26.43±4.31	20.27±2.98^a	16.47±2.96^a	11.45±2.58	6.52±1.61^a	3.50±0.86^ab	70.16±3.18^a	75.51±3.38^ac	82.63±3.03^ab
F			2.665^＊	5.084^＊＊	4.368^＊＊	2.468	16.528^＊＊	17.059^＊＊	5.762^＊＊	41.266^＊＊	48.088^＊＊

组别		n	WA（mm²）			LA（mm²）			WA%
组别		n	4级	5级	6级	4级	5级	6级	4级	5级	6级
正常组	33		26.04±4.36	19.17±3.07	15.50±3.38	12.03±4.03	7.53±2.35	4.26±1.61	68.79±4.91	72.35±4.96	78.58±5.86
COPD组	109		26.84±4.60	20.26±3.09^a	16.47±3.45^a	11.43±2.74	6.50±1.61^a	3.57±1.07^a	70.27±4.15^a	75.87±3.65^a	82.45±3.67^a
GOLDⅠ级组	29		26.96±3.91	20.10±2.73^a	16.03±2.39	11.48±2.18	6.52±1.62^a	3.81±1.25^a	70.19±3.65^a	75.73±4.11^a	81.31±3.86^a
GOLDⅡ级组	38		27.15±5.23^a	20.37±3.28^a	16.76±4.52^ab	11.36±3.28	6.46±1.62^a	3.47±1.12^ab	70.44±5.30^a	76.49±3.40^a	83.10±3.98^ab
GOLDⅢ＋Ⅳ级组	42		26.43±4.31	20.27±2.98^a	16.47±2.96^a	11.45±2.58	6.52±1.61^a	3.50±0.86^ab	70.16±3.18^a	75.51±3.38^ac	82.63±3.03^ab
F			2.665^＊	5.084^＊＊	4.368^＊＊	2.468	16.528^＊＊	17.059^＊＊	5.762^＊＊	41.266^＊＊	48.088^＊＊

部位	EI		MLD
部位	r_s	P	r_s	P
左肺上叶	-0.500	<0.001	0.431	<0.001
左肺下叶	-0.629	<0.001	0.524	<0.001
右肺上叶	-0.482	<0.001	0.431	<0.001
右肺中叶	-0.465	<0.001	0.366	<0.001
右肺下叶	-0.586	<0.001	0.491	<0.001

The correlation research of quantitative index of HRCT and lung function in patients with chronic obstructive pulmonary disease

Cite this article

RichHTML

PDF (PC)

Knowledge

Abstract

share this article

Figures/Tables 5

References 26

Related Articles 12

Recommended Articles

Metrics

Comments

支气管	WA		LA		WA%
支气管	r_s	P	r_s	P	r_s	P
4级	-0.039	0.711	0.112	0.092	-0.168	0.082
5级	-0.073	0.482	0.194	0.062	-0.201	0.036
6级	-0.125	0.229	0.175	0.092	-0.195	0.043

[1]	ZHU Pengfei, NIE Xiaohong, ZHOU Qian, ZHANG Meifeng, YAO Mengdie, ZHOU Qing, XIAO Zhu. Effects of enteral nutrition on pulmonary function and BODE index in elderly patients with stable chronic obstructive pulmonary disease [J]. Tianjin Medical Journal, 2023, 51(11): 1232-1236.
[2]	CHEN Jian, YANG Li, JIN Jie, WANG Lei, DONG Min, CHAI Guoxiang. Comparison of clinical effect of thoracic drainage microtube and thoracoscopy in treatment of emphysema complicated with giant pulmonary bullae [J]. Tianjin Medical Journal, 2022, 50(7): 761-765.
[3]	ZHENG Jiang-nan, XIAO Ying, ZOU Zhao-hua, WU Qiao-zhen, HU Xiao-yun, ZHANG Jian-feng, DU Huan. The value of inspiratory muscle training as a rehabilitation treatment in patients with chronic obstructive pulmonary disease [J]. Tianjin Medical Journal, 2019, 47(7): 735-738.
[4]	ZHANG Hai-jun, DONG Xiao-lei, LIN Cui, FANG You-fu, ZHANG Hong-yu. Characteristics and risk factors of pulmonary function changes in children with mycoplasma pneumoniae pneumonia [J]. Tianjin Medical Journal, 2019, 47(11): 1166-1169.
[5]	ZHUANG Yan, LAI Yanping. Assess the nutritional status of patients with chronic obstructive pulmonary disease by SGA [J]. Tianjin Med J, 2015, 43(8): 886-888.
[6]	Yi-Jiang MA HE Qing FENG Jing. Hepatic oxidative stress and coagulation status in rat model of pulmonary emphysema combined with intermittent hypoxia [J]. , 2015, 43(2): 117-120.
[7]	. Mesenchymal stem cells transplantation alleviates pulmonary emphysema and oxidative stress in rat [J]. , 2015, 43(2): 121-124.
[8]	ZENG Fanrui，ZHANG Linghui，SHA Hang，Liu Yongmou，WU Juan. Correlation of serum vitamin D level with pulmonary function related factors in adult asthma [J]. Tianjin Med J, 2015, 43(12): 1416-1419.
[9]	. The Mechanism underlying the Role of HIF-1α during Hepatocyte Apoptosis in Intermittent Hypoxia with Pulmonary Emphysema Rats [J]. , 2014, 42(2): 156-159 .
[10]	. Correlation study of Adiponectin and Chronic Obstructive Pulmonary Disease [J]. , 2014, 42(1): 38-40 .
[11]	. Preoperative enteral nutrition support treatment on the respiratory function of esophageal cancer patients with low pulmonary function [J]. , 2013, 41(3): 0-233 .
[12]	. The Clinical Effect Observation Of Feishu Capsule On The Steady Stage Period Of COPD [J]. , 2010, 38(10): 849-851 .